切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2020, Vol. 14 ›› Issue (02) : 105 -109. doi: 10.3877/cma.j.issn.1674-0785.2020.02.006

所属专题: 文献

临床研究

15例Xp11.2易位/TFE3基因融合相关性肾癌的临床病理特点分析
沈棋1,(), 胡帅1, 李峻1, 王静华1, 刘漓波1, 何群1   
  1. 1. 100034 北京大学第一医院泌尿外科,北京大学泌尿外科研究所,国家泌尿、男性生殖系肿瘤研究中心
  • 收稿日期:2020-01-14 出版日期:2020-02-15
  • 通信作者: 沈棋

Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: clinicopathological analysis of 15 cases

Qi Shen1,(), Shuai Hu1, Jun Li1, Jinghua Wang1, Libo Liu1, Qun He1   

  1. 1. Department of Urology, Peking University First Hospital; Institute of Urology, Peking University; National Urological Cancer Center, Beijing 100034, China
  • Received:2020-01-14 Published:2020-02-15
  • Corresponding author: Qi Shen
  • About author:
    Corresponding author: Shen Qi, Email:
引用本文:

沈棋, 胡帅, 李峻, 王静华, 刘漓波, 何群. 15例Xp11.2易位/TFE3基因融合相关性肾癌的临床病理特点分析[J]. 中华临床医师杂志(电子版), 2020, 14(02): 105-109.

Qi Shen, Shuai Hu, Jun Li, Jinghua Wang, Libo Liu, Qun He. Renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: clinicopathological analysis of 15 cases[J]. Chinese Journal of Clinicians(Electronic Edition), 2020, 14(02): 105-109.

目的

探讨Xp11.2易位/TFE3基因融合相关性肾癌的临床病理学特征、诊断要点及鉴别诊断。

方法

回顾性分析15例Xp11.2易位/TFE3基因融合相关性肾癌患者的临床特征、组织学特点、免疫组化及荧光原位杂交,并结合相关文献复习讨论。

结果

15例患者中,男性6例,女性9例,平均(31.3±9.3)岁。12例为体检偶然发现,临床主要症状表现为血尿和腰腹部疼痛。肿瘤直径1.5~15 cm,平均5.4 cm,3例诊断时已发生转移。10例标本大体呈实性,切面灰白多见,其次为杂色、灰褐,5例切面伴囊性变,5例可见出血及坏死区域。镜下观察可见肿瘤由嗜酸性细胞或透明细胞构成的乳头状、巢状及腺泡状结构,肿瘤细胞界限清楚,核仁较明显,间质主要为纤细的纤维血管间隔,4例可以见到砂砾体。免疫组织化学结果显示肿瘤细胞均弥漫表达TFE3、PAX-8及CD10,不同程度表达AE1/AE3、Vimentin、HMB45及AMACR/P504S,CAIX、CK7、CD117均阴性表达。所有病例TFE3荧光原位杂交检测存在TFE3信号分离。

结论

Xp11.2易位/TFE3基因融合相关性肾癌是一种罕见的肾细胞癌类型,女性高发于男性,其诊断主要依靠组织病理学、免疫组织化学标记TFE3荧光原位杂交来确诊。

Objective

To investigate the clinicopathological features, diagnosis, and differential diagnosis of Xp11.2 translocation/ TFE3 fusion-related renal cell carcinoma.

Methods

A total of 15 cases of Xp11.2 translocation/ TFE3 fusion-related renal cell carcinoma were analyzed with regard to clinical data, histology, immunohistochemistry, and fluorescence in situ hybridization (FISH) findings.

Results

Six patients were male and the other nine were female. Their mean age was (31.3±9.3) years. The main clinical manifestations were hematuria and waist pain. Mean tumor diameter was 5.4 cm (range, 1.5-15 cm). Ten cases of the gross specimens were solid and had a grey, yellow, or tan cut surface. Five cases of the gross specimens were cystic-solid. Microscopic examination showed that the distinctive histological pattern was papillary, nested, and acini-like structure. The tumor cells had a clear boundary, eosinophilic or clear cytoplasm, and prominent nucleoli. And in 4 cases, psammoma bodies were observed. Immunohistochemistry results showed that TFE3, PAX-8, and CD10 were diffusely expressed in all cases. The expression of AE1/AE3, vimentin, HMB45, and AMACR/P504S varied among cases. The expression of CAIX, CK7, and CD117 was negative in all cases. All cases showed positive results in the FISH assay.

Conclusion

Xp11.2 translocation/TFE3 gene fusion-associated renal cell carcinoma is a rare renal malignancy and mainly occurs in females. Its diagnosis relies mainly on histopathology, immunohistochemistry, and FISH assay.

图1 Xp11.2易位/TFE3基因融合相关性肾癌 肿瘤由嗜酸性细胞或透明细胞构成的乳头状、巢状及腺泡状结构,肿瘤细胞界限较清楚,胞浆丰富,嗜酸或透明,部分病例可见到砂砾体;图a、b为HE染色(×100);图c、d为HE染色(×200)
表1 15例Xp11.2易位/TFE3基因融合相关性肾癌免疫组化表达情况
图2 Xp11.2易位/TFE3基因融合相关性肾癌免疫组织化学染色(×200)
图3 Xp11.2易位/TFE3基因融合相关性肾癌TFE3荧光原位杂交检测 图a为女性病例,一个正常的融合信号和一对异常的红绿分离信号;图b为男性病例,一对异常的红绿分离信号
[1]
Ross H, Argani P. Xp11 translocation renal cell carcinoma [J]. Pathology, 2010, 42(4): 369-273.
[2]
Kmetec A, Jeruc J. Xp11. 2 translocation renal carcinoma in young adults; recently classified distinct subtype [J]. Radiol Oncol, 2014, 48(2): 197-202.
[3]
Komai Y, Fujiwara M, Fujii Y, et al. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry [J]. Clin Cancer Res, 2009, 15(4): 1170-1176.
[4]
Klatte T, Streubel B, Wrba F, et al. Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis [J]. Am J Clin Pathol, 2012, 137(5): 761-768.
[5]
Gong P, Zhuang Q, Wang K, et al. Adult-onset renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: 3 case reports and review of literature [J]. Medicine (Baltimore), 2018, 97(24): e1123.
[6]
Yang B, Duan H, Cao W, et al. Xp11 translocation renal cell carcinoma and clear cell renal cell carcinoma with TFE3 strong positive immunostaining: morphology immunohistochemistry, and FISH analysis [J]. Mod Pathol, 2019, 32(10): 1521-1535.
[7]
Argani P, MiT family translocation renal cell carcinoma [J]. Semin Diagn Pathol, 2015, 32(2): 103-113.
[8]
Qu Y, Gu C, Wang H, et al. Diagnosis of adults Xp11.2 translocation renal cell carcinoma by immunohistochemistry and FISH assays: clinicopathological data from ethnic Chinese population [J]. Sci Rep, 2016, 6: 21677
[9]
Argani P, Lal P, Hutchinson B, et al. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay [J]. Am J Surg Pathol, 2003, 27(6): 750-761.
[10]
Mosquera JM, Dal Cin P, Mertz KD, et al. Validation of a TFE3 break-apart FISH assay in Xp11.2 translocation renal cell carcinomas [J]. Diagn Mol Pathol, 2011, 20(3): 129-137.
[11]
Ross H, Martignoni G, Argani P. Renal cell carcinoma with clear cell and papillary features [J]. Arch Pathol Lab Med, 2012, 136(4): 391-399.
[1] 武壮壮, 张晓娟, 史泽洪, 史瑶, 原韶玲. 超声联合乳腺X线摄影及PR、Her-2预测高级别与中低级别乳腺导管原位癌的价值[J]. 中华医学超声杂志(电子版), 2023, 20(06): 631-635.
[2] 刘星辰, 刘娟, 魏宝宝, 刘洁, 刘辉. XIAP与XAF1异常表达与卵巢癌的相关性分析[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 419-427.
[3] 韩春颖, 王婷婷, 李艳艳, 朴金霞. 子宫内膜癌患者淋巴管间隙浸润预测因素研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(04): 403-409.
[4] 赵佳晖, 王永兴, 彭涛, 李明川, 魏德超, 韩毅力, 侯铸, 姜永光, 罗勇. 后腹腔镜根治性肾切除手术时间延长和术中出血量增多的影响因素分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(06): 575-580.
[5] 杨春亭, 毛云华, 罗云, 刘博皓. 孤立肾合并肾混合性上皮间质肿瘤一例报告并文献复习[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 407-409.
[6] 刘阳阳, 王梁, 戴志红, 郝建戈, 张力仁, 刘志宇. 腹膜后去分化脂肪肉瘤合并左肾透明细胞癌一例报告[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 412-414.
[7] 刘麒, 曾弘, 徐子昕, 方超, 黄铭, 郑俊炯, 吴少旭, 钟广正, 林天歆, 黄健, 董文. 乳头状肾细胞癌单中心11年临床诊治与预后分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 351-355.
[8] 董翔, 马文亮, 纪长威, 李笑弓, 张古田, 甘卫东, 郭宏骞. 回顾性评估肾细胞癌假包膜状态及其影响因素[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 356-360.
[9] 李国良, 吴凡, 李浩民, 江俊斌, 郭泽雄, 卓育敏, 马鑫, 赖彩永. 抽栓技术在完全腹腔镜左肾癌合并Ⅳ级腔静脉癌栓取出术的应用[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(04): 403-406.
[10] 陈伟, 周骏, 梁朝朝. 机器人辅助腹腔镜下右肾部分切除术治疗后肾腺瘤一例报告[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 293-293,298.
[11] 唐国军, 洪余德, 赵崇玉, 李辽源. 基于TCGA数据库Wnt相关长链非编码RNA构建肾乳头状细胞癌预后模型[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 270-275.
[12] 李峻峰, 李军, 孙勤丰, 孙建光, 孔祥兴. 九例结肠髓样癌的临床病理特征分析[J]. 中华结直肠疾病电子杂志, 2023, 12(03): 248-252.
[13] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
[14] 毛高才, 张建波, 袁一方, 毛小波, 戴慧勇, 王哲. 耳后淋巴结内涎腺透明细胞型嗜酸性腺瘤的诊断学特征[J]. 中华诊断学电子杂志, 2023, 11(04): 261-265.
[15] 刘迎, 尹嫚, 杨林青, 王云飞. 子宫颈浸润性复层产黏液的癌的诊断学特征并文献复习[J]. 中华诊断学电子杂志, 2023, 11(03): 173-177.
阅读次数
全文


摘要